Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LEMD3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | APOC4 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | FBXL22 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | GPBP1L1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | NPIPA8 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | SLC6A8 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | RP11-104H15.12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | STRA8 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | CENPL | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | ENOX2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |